RT Journal Article SR Electronic T1 Production and Supply of α-Particle–Emitting Radionuclides for Targeted α-Therapy JF Journal of Nuclear Medicine JO J Nucl Med FD Society of Nuclear Medicine SP 1495 OP 1503 DO 10.2967/jnumed.120.261016 VO 62 IS 11 A1 Valery Radchenko A1 Alfred Morgenstern A1 Amir R. Jalilian A1 Caterina F. Ramogida A1 Cathy Cutler A1 Charlotte Duchemin A1 Cornelia Hoehr A1 Ferrid Haddad A1 Frank Bruchertseifer A1 Haavar Gausemel A1 Hua Yang A1 Joao Alberto Osso A1 Kohshin Washiyama A1 Kenneth Czerwinski A1 Kirsten Leufgen A1 Marek Pruszyński A1 Olga Valzdorf A1 Patrick Causey A1 Paul Schaffer A1 Randy Perron A1 Samsonov Maxim A1 D. Scott Wilbur A1 Thierry Stora A1 Yawen Li YR 2021 UL http://jnm.snmjournals.org/content/62/11/1495.abstract AB Encouraging results from targeted α-therapy have received significant attention from academia and industry. However, the limited availability of suitable radionuclides has hampered widespread translation and application. In the present review, we discuss the most promising candidates for clinical application and the state of the art of their production and supply. In this review, along with 2 forthcoming reviews on chelation and clinical application of α-emitting radionuclides, The Journal of Nuclear Medicine will provide a comprehensive assessment of the field.